Parathyroid carcinoma: the Lahey Clinic experience

Area of Science:

• Endocrinology
• Surgical Oncology
• Oncologic Pathology

Background:

• Hyperparathyroidism is a condition characterized by excessive parathyroid hormone production.
• Parathyroid carcinoma is a rare endocrine malignancy, accounting for a small percentage of hyperparathyroidism cases.
• Distinguishing benign from malignant parathyroid disease preoperatively can be challenging.

Purpose of the Study:

• To analyze the clinical characteristics and outcomes of patients with parathyroid carcinoma.
• To evaluate the significance of serum calcium levels in differentiating parathyroid carcinoma from benign disease.
• To assess the effectiveness of surgical management strategies for parathyroid carcinoma.

Main Methods:

• Retrospective review of 301 hyperparathyroidism operations performed between 1942 and 1984.
• Analysis of patient demographics, serum calcium levels, and pathological findings.
• Evaluation of surgical techniques, including en bloc resection and neck dissection.
• Long-term follow-up to assess recurrence and mortality rates.

Main Results:

• Nine patients (3%) were diagnosed with parathyroid carcinoma.
• Patients with carcinoma had a higher mean serum calcium level (14.0 mg/dl) compared to those with benign disease (12.0 mg/dl).
• One death occurred due to unrelated lung cancer, with autopsy revealing parathyroid carcinoma recurrence; no other recurrences or deaths were reported.

Conclusions:

• Higher serum calcium levels may suggest parathyroid carcinoma.
• Intraoperative recognition of parathyroid carcinoma is crucial for appropriate management.
• En bloc resection, including ipsilateral thyroid lobectomy and tracheoesophageal groove dissection, is recommended.
• Radical neck dissection is reserved for extensive metastases or complex reoperations.